Showing results (121-130 of 147) with videos related to
Sort By:
Pageof 15
Alzheimer'S Research & Therapy|February 13, 2025
Plasma Hepcidin as a potential informative biomarker of Alzheimer disease and vascular dementiaConstance Delaby, Daniel Alcolea, Germain Busto, et al.Experimental Physiology|July 9, 2023
Lower systemic nitric oxide bioactivity, cerebral hypoperfusion and accelerated cognitive decline in formerly concussed retired rugby union playersThomas S Owens, Christopher J Marley, Thomas A Calverley, et al.Alzheimer'S Research & Therapy|October 3, 2020
Cerebrospinal fluid A beta 1-40 peptides increase in Alzheimer's disease and are highly correlated with phospho-tau in control individualsSylvain Lehmann, Julien Dumurgier, Xavier Ayrignac, et al.Aging Cell|October 17, 2022
A single short reprogramming early in life initiates and propagates an epigenetically related mechanism improving fitness and promoting an increased healthy lifespanQuentin Alle, Enora Le Borgne, Paul Bensadoun, et al.Scientific Reports|July 4, 2020
Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severityXavier Ayrignac, Emmanuelle Le Bars, Claire Duflos, et al.The Analyst|July 23, 2024
A candidate reference measurement procedure for the quantification of α-synuclein in cerebrospinal fluid using an SI traceable primary calibrator and multiple reaction monitoringLeran Zhang, Eva Illes-Toth, Adam Cryar, et al.Journal of Alzheimer'S Disease : JAD|February 22, 2020
Cerebrospinal Fluid and Plasma Biomarkers do not Differ in the Presenile and Late-Onset Behavioral Variants of Frontotemporal DementiaCecilia Marelli, Claire Hourregue, Laure-Anne Gutierrez, et al.The Lancet. Neurology|September 3, 2018
Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional studyJuan Fortea, María Carmona-Iragui, Bessy Benejam, et al.ACS Omega|March 21, 2022
Deciphering Black Extrinsic Tooth Stain Composition in Children Using MetaproteomicsChristophe Hirtz, Atef Mahmoud Mannaa, Estelle Moulis, et al.NPJ Precision Oncology|June 3, 2026
When effective anticancer therapies are, in fact, destabilizing the tumor's Group Phenotypic CompositionFrédéric Thomas, Antoine M Dujon, Andriy Marusyk, et al.Pageof 15